Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4654229)

Published in J Immunol on October 26, 2015

Authors

Rasmus Iversen1, M Fleur du Pré2, Roberto Di Niro2, Ludvig M Sollid2

Author Affiliations

1: Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway rasmus.iversen@rr-research.no.
2: Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway.

Articles cited by this

Predominant autoantibody production by early human B cell precursors. Science (2003) 13.14

Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42

Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med (2007) 6.13

Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05

Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol (2003) 5.51

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25

Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol (2002) 3.98

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73

B cell antigen receptor signaling 101. Mol Immunol (2004) 3.58

The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc (2009) 3.30

Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology (1998) 3.22

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10

Generation of T-cell receptor retrogenic mice. Nat Protoc (2006) 3.05

Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol (1998) 2.88

Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol (2000) 2.86

Stages of B cell differentiation in human lymphoid tissue. J Exp Med (1981) 2.49

Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut (1997) 1.60

Screening detects a high proportion of celiac disease in young HLA-genotyped children. J Pediatr Gastroenterol Nutr (2010) 1.51

High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry (2002) 1.49

High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44

Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther (2006) 1.39

Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med (2003) 1.38

Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38

Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol (2004) 1.23

Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res (1998) 1.20

Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol (2001) 1.19

Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem (2004) 1.15

Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol (2011) 1.11

Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol (2009) 1.07

Glycosyl-phosphatidylinositol linkage as a mechanism for cell-surface expression of immunoglobulin D. Nature (1992) 1.07

Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 1.06

The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One (2010) 1.05

Hydrolysis of gamma:epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem (1997) 0.99

Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut (2005) 0.98

The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta (2008) 0.96

A GPI-linked isoform of the IgD receptor regulates resting B cell activation. Nat Immunol (2002) 0.96

Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. J Immunol (1989) 0.95

Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. J Mol Biol (2005) 0.92

Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91

High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency. Clin Exp Immunol (2009) 0.91

Cellular transglutaminase has affinity for extracellular matrix. In Vitro Cell Dev Biol (1987) 0.87

Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. J Immunol (2005) 0.86

Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing. J Immunol (2015) 0.84

Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A (2014) 0.84

Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization. PLoS One (2015) 0.81

Serologic testing for celiac disease. Clin Chem (2002) 0.81